Abstract
Objective: This study was planned to evaluate the correlation between cost borne by the patient and medication adherence in common mental disorder patients during COVID-19 pandemic. Methods: A descriptive cross-sectional drug utilization study was undertaken in 200 patients. Pattern of psychotropic drugs usage was analyzed as per WHO/INRUD guidelines and average monthly cost borne by the patient/hospital per prescription was correlated with medication adherence of the patients. Results: The average monthly costs borne by patients and hospital were observed to be more during the pandemic as compared to pre-pandemic time. It was observed that patients bearing some cost on their own had significantly lower medication adherence compared to those patients whose cost of treatment was borne by the government-funded hospital (p-value of 0.017). The medication adherence in patients of mental disorders was found to be negatively correlated to the cost was borne by the patients. Conclusion: The COVID-19 pandemic has escalated the total cost borne by the patients as well as the financial burden on government-funded hospitals.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Current Pharmaceutical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
